Papaya seed extract sustained-release preparation and application thereof
A technology of papaya seeds and sustained-release preparations, applied in the field of medicine, to achieve the effects of high bioavailability, reduction of glutaraldehyde organic cross-linking agent, and high biosafety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach
[0041] In another specific embodiment, the XPO1 protein inhibitor drug is an XPO1 protein inhibitor antiviral drug, wherein the virus includes: human immunodeficiency virus (HIV), influenza virus, hepatitis B virus (HBV) , Hepatitis C Virus (HCV), Human Papillomavirus (HPV), Respiratory Syncytial Virus (RSV), Dengue Fever Virus (Dungee), Severe Acute Respiratory Syndrome Coronavirus, West Nile Virus, Herpes Simplex Virus (HSV) ), cytomegalovirus (CMV), or Merkel cell polyomavirus (MCV). Preferably, the virus includes: Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) or Human Papillomavirus (HPV).
[0042] The present invention modifies montmorillonite by adding edible acid, and mixes with chitosan and ethyl cellulose to prepare composite slow-release microspheres, which ensures that the benzyl isothiocyanate compound in the embedded papaya seed extract is Stability under acidic conditions inhibits its degradation. In addition, the papaya s...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap